Polypharmacy—the use of five or more medications—is highly prevalent among adults with cancer and multimorbidity, and is associated with high health service utilization, Canadian researchers have found. This was also true of younger adults, and most prevalent among individuals with lung cancer and those diagnosed with stage IV cancers.
The prevalence of polypharmacy overall was 46% before and 57% one year after diagnosis, according to researchers at Lakehead University, in Thunder